Dialysis

Panoramic Health Launches Scientific Advisory Board to Accelerate Innovation in Kidney Care

Retrieved on: 
Thursday, March 7, 2024
Doctor of Philosophy, Person, Dialysis, Health, University, Acute kidney injury, Health policy, Kidney disease, Diagnosis, Literature, Belding, Michigan, ASN, Bangladesh Technical Education Board, Chronic kidney disease, National Kidney Foundation, NIH, Johns Hopkins, National Academy of Medicine, UNC, Partnership, American Kidney Fund, CKD, Kidney, Biomarker, Prognosis, MPH, Research, Division, Public policy, Population health, FDA, National academy, Entrepreneurship, Society, Patient, Physician, Pharmaceutical industry

TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation. With a focus on uncovering and delivering cutting-edge treatments for patients with kidney disease, the advisory board will play a crucial role in guiding Panoramic Science, the company's clinical research division.

Key Points: 
  • TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation.
  • "At Panoramic Health, we are dedicated to redefining the standard of kidney care through innovation and collaboration," said Dr. Rajiv Poduval, Co-Founder and Executive Chairman of Panoramic Health.
  • "Our Scientific Advisory Board brings together exceptional expertise that will drive our efforts to enhance patient care and transform the evolving landscape of kidney disease treatment.
  • Panoramic Health leadership team members serving on the advisory board include:
    The establishment of the Scientific Advisory Board underscores Panoramic Health's commitment to driving innovation and improving the lives of patients with kidney disease.

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Retrieved on: 
Tuesday, March 5, 2024
Dialysis, Kidney disease, Patient, Caregiver, DaVita Inc., Fresenius Medical Care, IA Financial Group, Nursing

DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective today. The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.

Key Points: 
  • The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD.
  • The transaction in Chile closed effective today.
  • The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.
  • We look forward to building on our existing market expertise and the established quality of these centers through this transition."

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Retrieved on: 
Tuesday, March 5, 2024
Dialysis, Kidney disease, Patient, Caregiver, DaVita Inc., Fresenius Medical Care, IA Financial Group, Nursing

DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador. The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD. The transaction in Chile closed effective today. The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.

Key Points: 
  • The deal, which is consistent with DaVita's disciplined investment strategy, involves four separate acquisitions from Fresenius Medical Care for a total purchase price of $300M USD.
  • The transaction in Chile closed effective today.
  • The transactions in Ecuador, Colombia and Brazil remain subject to each country's respective anti-trust and regulatory approval processes, which are each expected to be completed at various times during 2024.
  • We look forward to building on our existing market expertise and the established quality of these centers through this transition."

Northwest Kidney Centers Opens Dialysis Museum at New Location

Retrieved on: 
Tuesday, March 5, 2024
Puget Sound, Chronic kidney disease, Hospital, Research, Quality of life, Dialysis, Artifact, Health education, Kidney disease, Health, Northwest Kidney Centers, University, History, Patient, Partnership

The first out-of-hospital dialysis organization in the world, nonprofit Northwest Kidney Centers was the proving ground for many technological advances displayed in the museum.

Key Points: 
  • The first out-of-hospital dialysis organization in the world, nonprofit Northwest Kidney Centers was the proving ground for many technological advances displayed in the museum.
  • "As the world's first outpatient dialysis provider, Northwest Kidney Centers has always been at the forefront of kidney care and innovation," said Rebecca Fox, president and CEO.
  • Northwest Kidney Centers will host an opening celebration of the dialysis museum from 4:30 to 6:30 p.m. During the event, the nonprofit dialysis provider will present the Clyde Shields Distinguished Service Award to longtime supporter, volunteer and former Northwest Kidney Centers board chair Rich Bloch.
  • Northwest Kidney Centers is a not-for-profit, community-based provider of kidney dialysis that works to expand access to better health outcomes through public health education and support of research into the causes and treatments of chronic kidney disease.

Healthy.io Expands Leadership Team, Appoints Becca LaFond as U.S. General Manager

Retrieved on: 
Tuesday, February 27, 2024
Olive, Kidney disease, Acquisition, Diabetes, Healthy.io, ACR, Conditional sentence, FDA, Dialysis, Growth, Risk, CKD, Patient, Policy, Urine, Public, Pharmaceutical industry

BOSTON, Feb. 27, 2024 /PRNewswire/ -- Healthy.io, the developer of the first and only FDA-cleared smartphone-powered at-home kidney test, today announced the appointment of Becca LaFond as the company's new U.S. General Manager.

Key Points: 
  • LaFond will work closely with Healthy.io partners to scale the commercialization of its Minuteful Kidney service while enhancing execution across payers, systems, and pharmaceutical companies.
  • LaFond brings over two decades of experience in the healthcare industry and expertise in optimizing operations through technology for better outcomes.
  • The addition of LaFond to Healthy.io's executive suite marks a continued expansion of its leadership team.
  • "We're excited to have Becca join the team to drive our next phase of expansion," said Healthy.io CEO Geoff Martin.

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

Retrieved on: 
Thursday, February 15, 2024
Oncology, Medical Supplies, Health, Surgery, Cardiology, Biotechnology, Acquisition, Marketing, Sale, Cadwalader, Medical laboratory scientist, Radiofrequency ablation, Dialysis, PICC, Nanoknife, Cadwalader, Wickersham & Taft, UBS, Cancer, Security (finance)

The transaction consists of AngioDynamics’ PICC, Midline and tip location products.

Key Points: 
  • The transaction consists of AngioDynamics’ PICC, Midline and tip location products.
  • This combined portfolio of products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023.
  • These products contributed approximately $5.5 million in annual sales during AngioDynamics’ fiscal year 2023.
  • The divestiture of the PICC and Midline businesses, together with the discontinuance of the radiofrequency ablation and Syntrax businesses, will reduce full-year fiscal 2024 revenue by approximately $50 million.

DoseMe Expands Vancomycin Hemodialysis Model

Retrieved on: 
Thursday, February 15, 2024
Technology, Health Technology, Software, Biotechnology, Health, Pharmaceutical, General Health, Data Management, Artificial Intelligence, BCPS, TDM, Toxicity, Obesity, HD, Dialysis, Vancomycin, Doctor of Pharmacy, Risk, Medicine, Patient, IHD, Medical device

DoseMe , a leading provider of model informed precision dosing, today announced the availability of its new Vancomycin Hemodialysis (HD) model.

Key Points: 
  • DoseMe , a leading provider of model informed precision dosing, today announced the availability of its new Vancomycin Hemodialysis (HD) model.
  • The vancomycin hemodialysis (HD) model enables personalized dosing that reduces the necessity for multiple blood draws for vancomycin levels.
  • Implementing this optimized model could further enhance precision and personalization of vancomycin therapy in hemodialysis patients.
  • Overall, integrating the optimized model with DoseMeRx has potential to improve vancomycin dosing accuracy and outcomes in the hemodialysis population.

Six Tips for Dating while on Dialysis

Retrieved on: 
Wednesday, February 14, 2024
Love, Social media, Anxiety, National Kidney Foundation, Kidney failure, Conditional sentence, Dialysis, Social, NKF, Life, Pew Research Center, Creativity, Kidney disease, Child, Travel, Depression

NEW YORK, Feb. 14, 2024 /PRNewswire/ -- Half of Americans think dating has gotten harder in the last ten years.1 Where does that leave someone looking for love with a serious illness, such as kidney failure? Dating is hard enough without the stress of treatments like dialysis. You may ask if dating can even be done when you have a major health condition. The answer is yes, dating on dialysis can absolutely be done. While chronic illness may make the logistics of dating a little more difficult, you are still capable of loving and deserving of love. Just in time for Valentine's Day, the National Kidney Foundation (NKF) is suggesting six tips to help anyone navigating the dating world while dealing with the stress of dialysis. 

Key Points: 
  • Dating is hard enough without the stress of treatments like dialysis.
  • The answer is yes, dating on dialysis can absolutely be done.
  • Just in time for Valentine's Day, the National Kidney Foundation (NKF) is suggesting six tips to help anyone navigating the dating world while dealing with the stress of dialysis.
  • For Valentine's Day, the NKF is suggesting six tips for anyone navigating the dating world while dealing with dialysis.

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

Retrieved on: 
Tuesday, February 13, 2024
Oxygen, International, Chronic kidney disease, Incidence, FDA, Food, Dialysis, Glomerular filtration rate, Pneumonia, Hemofiltration, IRI, Risk, Conference, IMV, Angiopoietin, CRAC, Survivor, COVID-19, Classification, Death, Acute kidney injury, EGFR, AHRF, Patient, Biomarker, AKI, Survival, Disease, Kidney disease, Medicine, GFR, Endothelium, IND, Mortality, Pharmaceutical industry

LA JOLLA, Calif., Feb. 13, 2024 /PRNewswire/ -- CalciMedica, Inc. (CalciMedica or the Company) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic diseases, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the Company's lead product candidate, Auxora™, a potent and selective small molecule inhibitor of Orai1-containing CRAC channels, to be evaluated in a Phase 2 trial in acute kidney injury (AKI) with associated acute hypoxemic respiratory failure (AHRF). CalciMedica expects to initiate the trial, named KOURAGE, in the first half of 2024 and data expected in 2025.

Key Points: 
  • CalciMedica expects to initiate the trial, named KOURAGE, in the first half of 2024 and data expected in 2025.
  • "Through KOURAGE, we aim to determine how Auxora can benefit patients with severe AKI and potentially reduce the high mortality rate associated with this disease."
  • AKI is classified as stages 1, 2 and 3 depending on the degree of kidney injury.
  • A single dose of Auxora after IRI increased GFR by 61% and decreased mononuclear (inflammatory) cell infiltration by 30%.

Dr. Lisandro Montalvo-Burke Joins Healthmap Solutions as Medical Director for Puerto Rico

Retrieved on: 
Tuesday, February 13, 2024
Private practice, Chronic kidney disease, Emergency, Psychology, National Kidney Foundation, MD, Medical director, University, Dialysis, Kidney disease, PR, CKD, Renal Physicians Association, Society, Sociedad, Morazán, Patient, ESRD, Nephrology, Hurricane Maria, Nursing

GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.

Key Points: 
  • GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.
  • Dr. Montalvo is a board-certified nephrologist and has been practicing nephrology in Canovanas, PR at his private practice since 2005.
  • He is a member of the American Society of Nephrology, Renal Physicians Association, National Kidney Foundation, and Sociedad de Nefrología e Hipertensión de Puerto Rico.
  • Healthmap has an all-star team here in Puerto Rico, and I am thrilled to be part of the organization.”